Amine-based cyclolipid compound or pharmaceutically acceptable salt thereof, lipid nanoparticle, and composition

TW202629556APending Publication Date: 2026-07-16GC BIOPHARMA CORP

View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office: TW · TW
Patent Type: Applications
Current Assignee / Owner: GC BIOPHARMA CORP
Filing Date: 2025-12-24
Publication Date: 2026-07-16

Application Information

Patent Timeline

24 Dec 2025

Application

16 Jul 2026

Publication

TW202629556A

IPC: C07D211/26; A61K9/127; A61K9/51; A61K31/7088; A61K47/18; A61K47/24; A61K47/28; A61K48/00; C07D211/22; C07D211/42; C07D211/62; C07D241/04; C07D265/30; C07D319/12

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗

Get free access to AI patent search and analysis

Check patentability, review prior art and ask IP Agent with full patent context.

Smart Images

Figure TWG2TA001069229_001
Figure TWG2TA001069229_002
Figure TWG2TA001069229_003

Patent Text Reader

Abstract

or a pharmaceutically acceptable salt thereof. The amine-based cyclolipid compound according to the present invention is used as an ionizable lipid, which is a component of a lipid nanoparticle for delivering a nucleic acid.

Need to check novelty before this filing date? Find Prior Art